Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-10-01
著者
-
Zucchetti Massimo
Laboratory Of Cancer Pharmacology Department Of Oncology Istituto Di Ricerche Farmacologiche "m
-
Zucchetti Massimo
Laboratory Of Cancer Chemotherapy Mario Negri Institute For Pharmacological Research
-
Sala Federica
Laboratory Of Cancer Pharmacology Department Of Oncology Istituto Di Ricerche Farmacologiche "m
-
Marangon Elena
Laboratory Of Cancer Pharmacology Department Of Oncology Istituto Di Ricerche Farmacologiche "m
-
BAGNATI Renzo
Department of Environmental Health, Istituto di Ricerche Farmacologiche "Mario Negri"
-
PACE Silvia
Sigma Tau SpA R&D
-
CAPOCASA Francesca
Sigma Tau SpA R&D
-
Pace Silvia
Sigma Tau Spa R&d
-
Bagnati Renzo
Department Of Environmental Health Istituto Di Ricerche Farmacologiche "mario Negri
-
Capocasa Francesca
Sigma Tau Spa R&d
関連論文
- Analysis of aplidine (dehydrodidemnin B), a new marine-derived depsipeptide, in rat biological fluids by liquid chromatography-tandem mass spectrometry
- Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study
- Development and validation of a LC-MS/MS method for the determination of the novel oral 1,14 substituted taxane derivatives, IDN 5738 and IDN 5839, in mouse plasma and its application to the pharmacokinetic study
- High-performance liquid chromatographic assay for the determination of the novel etoposide derivative dimethylaminoetoposide (NK611) and its metabolites in urine of cancer patients